Skip to content

DE · P4O.DE

Plan Optik AG

Programmatic access: valuation JSON for this ticker · catalog · agent briefing · agent card. Paid lookups: HTTP 402 then Payment-Authorization, or Authorization: Bearer ic_live_….

Sector
Technology · Hardware, Equipment & Parts
Headquarters
Elsoff 56479

Price · as of 2026-10-09

$8.56

Market cap 53.3M

Price history

The price history chart is shown only to users with a Pro subscription.

InvestorsCraft valuation

Fair value (AI, DCF / IC, Graham) for Plan Optik AG (P4O.DE) is available to Pro members and via the machine API.

  • AI valuation — available
  • Intrinsic / IC value — available
  • Upside vs price — available

Valuation history

Annual price overlaid with each model's fair value. Y-axis is log scale.

The valuation history chart is shown only to users with a Pro subscription.

Historic valuation ratios

Pick a category, then toggle metrics to compare.

Historic valuation ratios are shown only to users with a Pro subscription.

USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Plan Optik AG

        Plan Optik AG manufactures and sells structured wafers in Germany. The company offers substrate wafers comprising borosilicate, quartz, fused silica, alkaline free, and silicon-on-glass wafers; carriers and tools, such as chemical release, thermal release, laser release, and mechanical release carrier wafers, as well as adapter wafer and handling tools; packaging wafers, including through hole wafers, cavity wafers, trenched wafers, customized cap solutions, and wafers with structured SI-layers. It also provides interposers, which include glass interposers, SI interposers, through glass vias, and redistribution layers; and microfluidics, including micro reactors, fluidic chips, flow chemistry sets, and sensors, as well as services, such as mechanical processing, patterning, wafer thinning, coating, wire sawing, and bonding services. It serves consumer electronics, automotive, aerospace, chemistry, and pharmaceutical industries. The company is headquartered in Elsoff, Germany.

        CEO
        Michael Schilling
        Employees
        102
        Beta
        0.48

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice.